Page last updated: 2024-12-08
2-nitroimidazole-1-acetohydroxamic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 159484 |
| SCHEMBL ID | 5312329 |
| MeSH ID | M0161268 |
Synonyms (11)
| Synonym |
|---|
| kih 801 |
| n-hydroxy-2-nitro imidazole-1-acetamide |
| kih-801 |
| 1h-imidazole-1-acetamide, n-hydroxy-2-nitro- |
| 117259-20-8 |
| n-hydroxy-2-(2-nitroimidazol-1-yl)acetamide |
| AKOS006273708 |
| kih-802 |
| 2-nitroimidazole-1-acetohydroxamic acid |
| SCHEMBL5312329 |
| DTXSID80151746 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.26
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.26) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (28.57%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (71.43%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||